Sign In
Buy MNOV
$1.36
+0.0600 (+4.62%)
At Close: Jun 23, 2026
MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (MNOV) and the JASDAQ Market of the Tokyo Stock Exchange (Code Number: 4875), today announced positive preclinical find
LA JOLLA, Calif., June 25, 2020 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and...
Here's a roundup of top developments in the biotech space over the last 24 hours:Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 23) * ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) * Accel
MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (MNOV) and the JASDAQ Market of the Tokyo Stock Exchange (Code Number: 4875), today announced that it has received
6 Stocks That Could Jump Higher
12:00am, Tuesday, 16'th Jun 2020
Stocks Analysis by Harry Boxer covering: Celsion Corp, Celldex Therapeutics Inc, Digital Ally Inc, Dynavax Technologies Corporation. Read Harry Boxer's latest article on Investing.com
89bio (NASDAQ:ETNB) vs. MediciNova (NASDAQ:MNOV) Financial Contrast
03:26am, Sunday, 14'th Jun 2020
89bio (NASDAQ:ETNB) and MediciNova (NASDAQ:MNOV) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendatio
Hedge Funds Are Cashing Out Of MediciNova, Inc. (MNOV)?
04:31pm, Friday, 12'th Jun 2020
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data. Insider Monkey finished processing 821 13F filing
MNOV: Multiple ‘Shots on Goal’ Provide Substantial Potential Upside…
03:30pm, Friday, 01'st May 2020
By David Bautz, PhD NASDAQ:MNOV READ THE FULL MNOV RESEARCH REPORT Business Update Multiple Reasons for MediciNova to Move Higher MediciNova, Inc. (NASDAQ:MNOV) is a biopharmaceutical company focused
MediciNova, Inc. (NASDAQ:MNOV) Expected to Announce Earnings of -$0.08 Per Share
10:40am, Thursday, 30'th Apr 2020
Analysts expect MediciNova, Inc. (NASDAQ:MNOV) to post ($0.08) earnings per share for the current fiscal quarter, Zacks reports. Zero analysts have issued estimates for MediciNova’s earnings. Medici
Have Insiders Been Buying MediciNova, Inc. (NASDAQ:MNOV) Shares This Year?
02:20pm, Monday, 27'th Apr 2020
We often see insiders buying up shares in companies that perform well over the long term. Unfortunately, there are...
MediciNova Receives Notice of Allowance for Second Patent Covering MN-166 (ibudilast) for the Treatment of Glioblastoma
10:14am, Tuesday, 21'st Apr 2020MediciNova Receives Notice of Allowance for Second Patent Covering MN-166 (ibudilast) for the Treatment of Glioblastoma
11:00pm, Monday, 20'th Apr 2020
MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (MNOV) and the JASDAQ Market of the Tokyo Stock Exchange (Code Number: 4875), today announced that it has received a No
Cubist Systematic Strategies LLC Acquires New Shares in MediciNova, Inc. (NASDAQ:MNOV)
09:24am, Monday, 20'th Apr 2020
Cubist Systematic Strategies LLC acquired a new stake in MediciNova, Inc. (NASDAQ:MNOV) in the fourth quarter, according to its most recent filing with the SEC. The fund acquired 10,800 shares of the
MediciNova Receives Notice of Allowance for Second Patent Covering MN-–66 (ibudilast) for the ...
12:00am, Monday, 20'th Apr 202078 Biggest Movers From Yesterday
08:45am, Wednesday, 15'th Apr 2020
Gainers
Sonnet BioTherapeutics Holdings, Inc. (NASDAQ: SONN) shares climbed 61.7% to close at $7.99 on Tuesday.
NeuroMetrix, Inc. (NASDAQ: NURO) shares gained 58.7% to close at $...
